The effect of the PNPLA3 I148M genetic variation is significant, with each allele having approximately a 2-fold increase in the odds of NAFLD and a 3-fold increase in the odds of NASH and HCC (118). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.